MyBlueDotsMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) MyBlueDots8 months ago01 mins FOSTER CITY, Calif.–(BUSINESS WIRE)–Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Go to Source Author: Post navigation Previous: Mettler-Toledo International Inc. to Host Fourth Quarter 2024 Earnings Conference CallNext: Clinical trial highlights promising new treatment for intestinal worms